Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics
Sarah K. Tasian, Stephen P. Hunger
British Journal of Haematology (2016) Vol. 176, Iss. 6, pp. 867-882
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia
David T. Teachey, Ching‐Hon Pui
The Lancet Oncology (2019) Vol. 20, Iss. 3, pp. e142-e154
Open Access | Times Cited: 216
Precision medicine in pediatric oncology
Suzanne J. Forrest, Birgit Geoerger, Katherine A. Janeway
Current Opinion in Pediatrics (2017) Vol. 30, Iss. 1, pp. 17-24
Open Access | Times Cited: 129
Precision medicine in acute lymphoblastic leukemia
Ching‐Hon Pui
Frontiers of Medicine (2020) Vol. 14, Iss. 6, pp. 689-700
Open Access | Times Cited: 112
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Stéphanie Vairy, Júlia Lopes Garcia, Pierre Teira, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 3885-3898
Open Access | Times Cited: 96
The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities
Thai Hoa Tran, Stephen P. Hunger
Seminars in Cancer Biology (2020) Vol. 84, pp. 144-152
Closed Access | Times Cited: 91
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia
Changya Chen, Wenbao Yu, Fatemeh Alikarami‬, et al.
Blood (2021) Vol. 139, Iss. 14, pp. 2198-2211
Open Access | Times Cited: 64
Epigenetics in pediatric acute lymphoblastic leukemia
Jessica Nordlund, Ann‐Christine Syvänen
Seminars in Cancer Biology (2017) Vol. 51, pp. 129-138
Open Access | Times Cited: 75
Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes, et al.
Frontiers in Bioengineering and Biotechnology (2017) Vol. 5
Open Access | Times Cited: 73
Precision medicine in pediatric oncology
Stefan Burdach, Mike‐Andrew Westhoff, Maximilian Felix Steinhauser, et al.
Molecular and Cellular Pediatrics (2018) Vol. 5, Iss. 1
Open Access | Times Cited: 41
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia
Joanna Pierro, Laura Hogan, Teena Bhatla, et al.
Expert Review of Anticancer Therapy (2017) Vol. 17, Iss. 8, pp. 725-736
Open Access | Times Cited: 40
Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies
Borahm Kim, Hyeonah Lee, Saeam Shin, et al.
Journal of Molecular Diagnostics (2018) Vol. 21, Iss. 1, pp. 163-170
Open Access | Times Cited: 39
KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease
Michelle O. Forgione, Barbara J. McClure, Laura N. Eadie, et al.
Cancer Letters (2019) Vol. 469, pp. 410-418
Closed Access | Times Cited: 36
(Immuno)proteasomes as therapeutic target in acute leukemia
Jacqueline Cloos, Margot S. F. Roeten, N. Franke, et al.
Cancer and Metastasis Reviews (2017) Vol. 36, Iss. 4, pp. 599-615
Open Access | Times Cited: 33
Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing
Honghong Zhang, Hongsheng Wang, Xiaowen Qian, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study
Albert Stuart Reece, Gary Kenneth Hulse
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Novel therapy for childhood acute lymphoblastic leukemia
Raoul Santiago, Stéphanie Vairy, Daniel Sinnett, et al.
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 11, pp. 1081-1099
Closed Access | Times Cited: 32
Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers
Bing He, Peng Gao, Yangyang Ding, et al.
Science Advances (2020) Vol. 6, Iss. 30
Open Access | Times Cited: 24
Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
Huan Xu, Hui Yu, Runming Jin, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3349-3349
Open Access | Times Cited: 23
Fatty acid synthase, a novel poor prognostic factor for acute lymphoblastic leukemia which can be targeted by ginger extract
Maryam Ghaeidamini, Soheila Rahgozar, Somayeh Rahimi Babasheikhali, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies
Thai Hoa Tran, Avanthi Tayi Shah, Mignon L. Loh
Clinical Cancer Research (2017) Vol. 23, Iss. 18, pp. 5329-5338
Closed Access | Times Cited: 23
Genetic variants and clinical significance of pediatric acute lymphoblastic leukemia
Honghong Zhang, Hongsheng Wang, Xiaowen Qian, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 14, pp. 296-296
Open Access | Times Cited: 22
Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012–2016
Ingrid M. Montes‐Rodríguez, Marievelisse Soto‐Salgado, Carlos R. Torres‐Cintrón, et al.
Cancer Epidemiology Biomarkers & Prevention (2023) Vol. 32, Iss. 8, pp. 1030-1037
Open Access | Times Cited: 6
Role of miRNAs in Treatment Response and Toxicity of Childhood Acute Lymphoblastic Leukemia
Maitane Umerez, Susana García‐Obregón, Idoia Martín‐Guerrero, et al.
Pharmacogenomics (2018) Vol. 19, Iss. 4, pp. 361-373
Closed Access | Times Cited: 19
Long non-coding RNAs in leukemia: biology and clinical impact
Tim Lammens, Kaat Durinck, Annelynn Wallaert, et al.
Current Opinion in Hematology (2017) Vol. 24, Iss. 4, pp. 353-358
Closed Access | Times Cited: 18
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors
Chengjing Zhou, Rizvan C Uluisik, Jesse W. Rowley, et al.
Experimental Hematology (2022) Vol. 112-113, pp. 24-34
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top